BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Anulex Technologies, Inc. Announces FDA Clearance of the fiXate™ Tissue Band


9/20/2011 10:05:23 AM

New technology aids secure placement of spinal cord stimulator leads quickly and consistently

MINNETONKA, Minn.--(BUSINESS WIRE)--Anulex Technologies, Inc., a privately held medical device manufacturer, has announced the U.S. Food and Drug Administration (FDA) clearance to market the fiXate™ Tissue Band product, designed to secure Spinal Cord Stimulation (SCS) lead anchors to the fascia or interspinous/supraspinous ligament in patients with chronic, intractable pain of the trunk and/or limbs.

The Anulex Technologies fiXate™ Tissue Band provides more consistent SCS lead anchor securement by offering a novel delivery system that facilitates efficient fixation to the surrounding tissue. The fiXate™ Tissue Band System is compatible with most commercially available spinal cord stimulation lead anchors.

Dr. Richard Bowman from the Center of Pain Relief in West Virginia had this to say after performing the first fiXate™ Tissue Band case: “This product addresses a need physicians have raised, enhancing confidence in the consistency of Spinal Cord Stimulation lead fixation while reducing procedure times.” Jeff Peters, Anulex’s Executive Chairman, goes on to say, “with the clearance of the fiXate Tissue Band, Anulex continues to demonstrate its commitment to developing novel and clinically relevant solutions for soft tissue fixation and repair.”

About Anulex Technologies, Inc.
Anulex Technologies, Inc. is dedicated to the development and commercialization of unique and proprietary soft tissue repair and fixation products. This latest clearance builds on our existing product platform which includes the Xclose™ Plus Tissue Repair System and the Versaclose™ Tissue Repair System which utilize proprietary Invisiloc™ Technology enabling surgeons to easily re-approximate soft tissue to facilitate the healing process. More information on the Company can be found at www.anulex.com.

fiXate, Xclose, Versaclose and Anulex are trademarks of Anulex Technologies, Inc. Contacts

Anulex Technologies, Inc. Dick Young, Marketing Manager 952-224-4057 dyoung@anulex.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->